CBIO Q1 2017 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$337M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$54,339

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+100.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$842,847

Balance Sheet

Total Assets

$37M

Total Liabilities

$5M

Stockholders' Equity

$32M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$54,339	$0	—
Operating Income	-$8M	-$8M	-5.2%
Net Income	-$8M	-$8M	-5.0%